Veterinary Diagnostics Market by Technology (PCR, ELISA, Lateral Flow Assay, Molecular Diagnostics, Immunodiagnostics), Product (Consumables, Instruments), Animal (Companion, Livestock, Swine), Application (Infectious, Bacteria) - Global Forecast to 2030
The global veterinary diagnostics market is projected to reach USD 5.36 billion by 2030 from USD 3.68 billion in 2025, at a CAGR of 7.8% during the forecast period. A key growth driver for market growth includes rising ownership and the domestication of animals, particularly in urban and high-income regions. Pet owners require high-quality animal medical care, including preventive diagnostics, routine health screenings, and disease monitoring. The increasing prevalence of zoonotic diseases, such as avian influenza, leptospirosis, brucellosis, and rabies, also contributes to the market's growth. Technological advancements in real-time PCR, next-generation sequencing (NGS), microfluidics, portable diagnostic analyzers, and artificial intelligence are enhancing the accuracy, speed, and accessibility of diagnostic testing.
By product, the instruments segment is projected to grow at the highest CAGR during the forecast period.
By product, the market is segmented into consumables and instruments. The instruments segment is projected to grow at the highest CAGR during the forecast period. The instruments include diagnostic test analyzers and portable analyzers. These analyzers measure the physiologically significant substances present in body fluids (blood, serum, plasma, and urine) and feces of animals. Increasing technological advancements and the development of AI-enabled instruments for veterinary diagnostics are expected to fuel the market adoption in this segment during the forecast period.
By technology, the molecular diagnostics segment is estimated to grow at the highest CAGR during the forecast period.
By technology, the molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. This segment includes PCR tests, microarray tests, and nucleic acid sequencing technologies. The high growth rate of this segment is attributed to the increasing incidence of infectious and zoonotic diseases, which further increases the demand for precise and rapid diagnostic solutions. Molecular diagnostics allow the identification of specific pathogens, genetic disorders, and antimicrobial resistance, which is critical for the timely treatment of various diseases. Technological advancements in molecular diagnostic tests, such as PCR and next-generation sequencing, also contribute to the market's growth.
By region, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.
The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period owing to the rising awareness about animal health, the increasing per capita income, favorable government initiatives for pet adoption, and the increasing production of livestock products in emerging economies. The rising pet ownership in rapidly urbanizing economies such as China, India, Indonesia, and South Korea is also expected to drive the market growth during the forecast period.
Breakdown of supply-side primary interviews:
The market study covers the veterinary diagnostics market across various segments. It aims to estimate the market size and the growth potential across different segments by product, application, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall veterinary diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (rise in companion animals, growing demand for products derived from animals, increased zoonotic disease cases, increase in pet insurance, increase in disease control and disease prevention measures), restraints (rising pet cost care and high cost of diagnostic tests), opportunities (high growth potential of emerging economies), and challenges (lack of animal health awareness and shortage of veterinary practitioners) influencing the growth of the veterinary diagnostics market Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by product, application, technology, animal type, end user, and region. Product Enhancement/Innovation: Detailed insights into upcoming trends and product launches in the global veterinary diagnostics market. Market Development: Comprehensive information on the lucrative emerging markets by product, technology, animal type, application, end user, and region. Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global veterinary diagnostics market. Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global veterinary diagnostics market.
By product, the instruments segment is projected to grow at the highest CAGR during the forecast period.
By product, the market is segmented into consumables and instruments. The instruments segment is projected to grow at the highest CAGR during the forecast period. The instruments include diagnostic test analyzers and portable analyzers. These analyzers measure the physiologically significant substances present in body fluids (blood, serum, plasma, and urine) and feces of animals. Increasing technological advancements and the development of AI-enabled instruments for veterinary diagnostics are expected to fuel the market adoption in this segment during the forecast period.
By technology, the molecular diagnostics segment is estimated to grow at the highest CAGR during the forecast period.
By technology, the molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. This segment includes PCR tests, microarray tests, and nucleic acid sequencing technologies. The high growth rate of this segment is attributed to the increasing incidence of infectious and zoonotic diseases, which further increases the demand for precise and rapid diagnostic solutions. Molecular diagnostics allow the identification of specific pathogens, genetic disorders, and antimicrobial resistance, which is critical for the timely treatment of various diseases. Technological advancements in molecular diagnostic tests, such as PCR and next-generation sequencing, also contribute to the market's growth.
By region, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.
The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period owing to the rising awareness about animal health, the increasing per capita income, favorable government initiatives for pet adoption, and the increasing production of livestock products in emerging economies. The rising pet ownership in rapidly urbanizing economies such as China, India, Indonesia, and South Korea is also expected to drive the market growth during the forecast period.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
- By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
- By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
- By Company Type: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
- By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
- By Region: North America (40%), Europe (25%), the Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
The market study covers the veterinary diagnostics market across various segments. It aims to estimate the market size and the growth potential across different segments by product, application, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall veterinary diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS & REGIONS COVERED
1.2.3 YEARS CONSIDERED
1.3 MARKET STAKEHOLDERS
1.4 LIMITATIONS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ANALYSIS
2.6 RESEARCH ASSUMPTIONS
2.6.1 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
2.8 RESEARCH LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
4.3 VETERINARY DIAGNOSTICS MARKET: REGIONAL MIX
4.4 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Growth in companion animal population
5.1.1.2 Increasing demand for animal-derived food products
5.1.1.3 Growing concerns about infectious zoonotic diseases
5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
5.1.1.6 Growing focus on disease control & prevention measures
5.1.2 RESTRAINTS
5.1.2.1 Rising pet care costs
5.1.2.2 High cost of veterinary diagnostic tests
5.1.3 OPPORTUNITIES
5.1.3.1 Growth potential of emerging economies
5.1.3.2 Integration of AI & ML
5.1.4 CHALLENGES
5.1.4.1 Low animal healthcare awareness in emerging countries
5.1.4.2 Shortage of veterinary practitioners in emerging economies
5.2 INDUSTRY TRENDS
5.2.1 ADOPTION OF MULTIPLE TEST PANELS
5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Portable instruments for POC diagnostic services
5.3.1.2 Biosensor-based diagnostic systems
5.3.2 ADJACENT TECHNOLOGIES
5.3.2.1 Wearable biosensors & remote monitoring devices
5.3.2.2 Development of rapid & sensitive veterinary diagnostic kits
5.3.2.3 Breath & saliva-based diagnostic tools
5.3.2.4 Microfluidics & Lab-on-chip devices
5.3.3 COMPLEMENTARY TECHNOLOGIES
5.3.3.1 AI-driven diagnostic platforms
5.3.3.2 Next-generation Sequencing (NGS)
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY LANDSCAPE
5.5.1 REGULATORY ANALYSIS
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Rest of the world
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE DATA FOR HS CODE 9018
5.7.1.1 Import data for HS Code 9018
5.7.1.2 Export data for HS Code 9018
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2022–2024
5.8.1.1 Average selling price trend of key players, by product, 2022–2024
5.8.2 AVERAGE SELLING PRICE, BY REGION
5.8.2.1 Average selling price of clinical chemistry analyzers and blood gas & electrolyte analyzers, by region, 2024
5.8.2.2 Average selling price trend of clinical chemistry reagent clips & cartridges, by region, 2022–2024
5.8.2.3 Average selling price trend of clinical chemistry analyzers, by region, 2022–2024
5.8.2.4 Average selling price trend of blood glucose strips, by region, 2022–2024
5.8.2.5 Average selling price trend of glucose monitors, by region, 2022–2024
5.8.2.6 Average selling price trend of blood gas & electrolyte reagent clips/cartridges, by region
5.8.2.7 Average selling price trend of blood gas & electrolyte analyzers, by region, 2022–2024
5.9 REIMBURSEMENT ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2025–2026
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 BUYING CRITERIA
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI ON VETERINARY DIAGNOSTICS MARKET
5.13.1 INTRODUCTION
5.13.2 MARKET POTENTIAL IN VETERINARY DIAGNOSTICS ECOSYSTEM
5.13.3 AI-USE CASES
5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS
5.14 ECOSYSTEM/MARKET MAP
5.15 VALUE CHAIN ANALYSIS
5.16 SUPPLY CHAIN ANALYSIS
5.17 ADJACENT MARKETS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 TRUMP TARIFF IMPACT ON VETERINARY DIAGNOSTICS MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES
5.19.3 PRICE IMPACT ANALYSIS
5.19.4 IMPACT ON COUNTRY/REGION
5.19.5 IMPACT ON END-USE INDUSTRIES
6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 RECURRING NATURE TO BOOST DEMAND
6.3 INSTRUMENTS
6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET
7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 IMMUNODIAGNOSTICS
7.2.1 LATERAL FLOW ASSAYS
7.2.1.1 Lateral flow rapid tests
7.2.1.1.1 Ability to provide real-time insights to drive market
7.2.1.2 Lateral flow strip readers
7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
7.2.2 ELISA
7.2.2.1 Cost-effectiveness and ease of use to drive market
7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
7.2.3.1 Increasing incidence of allergies in companion animals to fuel market
7.2.4 IMMUNOASSAY ANALYZERS
7.2.4.1 High sensitivity & specificity for biomarker detection to drive market
7.2.5 RADIOIMMUNOASSAYS
7.2.5.1 Measurement of hormone levels and detection of specific proteins to fuel market
7.2.6 OTHER IMMUNODIAGNOSTIC PRODUCTS
7.3 CLINICAL BIOCHEMISTRY
7.3.1 CLINICAL CHEMISTRY ANALYSIS
7.3.1.1 Clinical chemistry reagent clips & cartridges
7.3.1.1.1 Rising number of screening tests to fuel market
7.3.1.2 Clinical chemistry analyzers
7.3.1.2.1 Increasing installation of clinical chemistry analyzers to propel market
7.3.2 GLUCOSE MONITORING
7.3.2.1 Blood glucose strips
7.3.2.1.1 Growing demand in home care settings to fuel market
7.3.2.2 Glucose monitors
7.3.2.2.1 Growing incidence of diabetes in pet animals to fuel adoption
7.3.2.3 Urine glucose strips
7.3.2.3.1 Increasing risk of DKA in animals to propel market
7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS
7.3.3.1 Blood gas & electrolyte reagent clips & cartridges
7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market
7.3.3.2 Blood gas & electrolyte analyzers
7.3.3.2.1 Determination of blood oxygen & carbon dioxide levels to drive market
7.4 MOLECULAR DIAGNOSTICS
7.4.1 PCR TESTS
7.4.1.1 Increased laboratory usage in proteomics & genomics to support growth
7.4.2 MICROARRAYS
7.4.2.1 Growing applications of biochips in identifying infectious diseases to drive market
7.4.3 NUCLEIC ACID SEQUENCING
7.4.3.1 Identification of pathogens to fuel market
7.4.4 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
7.5 HEMATOLOGY
7.5.1 HEMATOLOGY CARTRIDGES
7.5.1.1 Complete blood analysis capabilities to fuel market
7.5.2 HEMATOLOGY ANALYZERS
7.5.2.1 Adoption by veterinary hospitals & clinics to support market growth
7.6 URINALYSIS
7.6.1 URINALYSIS CLIPS & CARTRIDGES/PANELS
7.6.1.1 Detection of electrolytes to boost adoption
7.6.2 URINE ANALYZERS
7.6.2.1 Development of advanced analyzers for POC testing to support market growth
7.6.3 URINE TEST STRIPS
7.6.3.1 Increasing prevalence of CKD in cats & dogs to drive market
7.7 OTHER TECHNOLOGIES
8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 COMPANION ANIMALS
8.2.1 DOGS
8.2.1.1 High insurance coverage and availability of reimbursements to drive market
8.2.2 CATS
8.2.2.1 Increasing pet cat population to support market uptake
8.2.3 HORSES
8.2.3.1 Growing awareness regarding equine health to fuel market
8.2.4 OTHER COMPANION ANIMALS
8.3 LIVESTOCK
8.3.1 CATTLE
8.3.1.1 Growing consumption of dairy products to drive market
8.3.2 PIGS
8.3.2.1 Increasing incidence of infectious diseases to fuel market
8.3.3 POULTRY
8.3.3.1 Increasing demand for poultry meat contributes to market growth
8.3.4 OTHER LIVESTOCK ANIMALS
9 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 INFECTIOUS DISEASES
9.2.1 BACTERIAL INFECTIONS
9.2.1.1 Rapid spread of E. Coli to drive market
9.2.2 VIRAL INFECTIONS
9.2.2.1 High mutation rate to ensure continued demand for diagnostics
9.2.3 PARASITIC INFECTIONS
9.2.3.1 Presence of parasitic infections to fuel market
9.2.4 OTHER INFECTIONS
9.3 ENDOCRINOLOGY
9.3.1 GROWING RISK OF DIABETES TO BOOST DEMAND
9.4 CARDIOLOGY
9.4.1 INCREASING CASES OF CVD IN DOGS TO FUEL MARKET
9.5 ONCOLOGY
9.5.1 HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET
9.6 OTHER APPLICATIONS
10 VETERINARY DIAGNOSTICS MARKET, BY END USER
10.1 INTRODUCTION
10.2 VETERINARY REFERENCE LABORATORIES
10.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
10.3 VETERINARY HOSPITALS & CLINICS
10.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
10.4 POINT-OF-CARE/IN-HOUSE TESTING
10.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
10.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
10.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
11 VETERINARY DIAGNOSTICS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 High veterinary healthcare expenditure to drive market
11.2.3 CANADA
11.2.3.1 Growing pet adoption to drive market
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Rising awareness of zoonotic diseases to fuel market
11.3.3 UK
11.3.3.1 Increasing pet ownership to drive market
11.3.4 FRANCE
11.3.4.1 Willingness of pet owners to spend on pet health to drive market
11.3.5 ITALY
11.3.5.1 Growing consumption of meat & dairy products to drive market
11.3.6 SPAIN
11.3.6.1 Growing demand for poultry products to fuel market
11.3.7 NETHERLANDS
11.3.7.1 Developments in veterinary diagnostic products to support market growth
11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Increasing incidence of zoonotic diseases to propel market
11.4.3 JAPAN
11.4.3.1 Increasing pet expenditure to support market growth
11.4.4 INDIA
11.4.4.1 Increasing demand for dairy products to drive market
11.4.5 AUSTRALIA
11.4.5.1 Rise in pet ownership to support market growth
11.4.6 SOUTH KOREA
11.4.6.1 Rising need for specialized veterinary services to drive market
11.4.7 NEW ZEALAND
11.4.7.1 Focus on pet insurance to aid market
11.4.8 VIETNAM
11.4.8.1 Growing focus on disease surveillance to drive market
11.4.9 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Growth in livestock industry to boost demand
11.5.3 MEXICO
11.5.3.1 Increasing focus on poultry-associated products to support market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Kingdom of Saudi Arabia (KSA)
11.6.2.1.1 Technology advancements in veterinary diagnostics to boost demand
11.6.2.2 United Arab Emirates (UAE)
11.6.2.2.1 Favorable government support for vet diagnostics to drive market
11.6.2.3 Other GCC Countries
11.6.3 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.3 REVENUE ANALYSIS, 2020–2024
12.4 MARKET SHARE ANALYSIS
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Technology footprint
12.5.5.5 Animal type footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups
12.7 BRAND/PRODUCT COMPARATIVE ANALYSIS
12.8 R&D EXPENDITURE OF KEY PLAYERS
12.9 COMPANY VALUATION & FINANCIAL METRICS
12.9.1 FINANCIAL METRICS
12.9.2 COMPANY VALUATION
12.10 COMPETITIVE SCENARIO
12.10.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS
12.10.2 DEALS
12.10.3 EXPANSIONS
12.10.4 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 IDEXX LABORATORIES, INC.
13.1.1.1 Business overview
13.1.1.2 Products/Services offered
13.1.1.3 Recent developments
13.1.1.3.1 Product/Service launches, enhancements, and approvals
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 ZOETIS SERVICES LLC
13.1.2.1 Business overview
13.1.2.2 Products/Services offered
13.1.2.3 Recent developments
13.1.2.3.1 Product/Service launches, enhancements, and approvals
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 THERMO FISHER SCIENTIFIC INC.
13.1.3.1 Business overview
13.1.3.2 Products/Services offered
13.1.3.3 MnM view
13.1.3.3.1 Key strengths
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses & competitive threats
13.1.4 ANTECH DIAGNOSTICS, INC.
13.1.4.1 Business overview
13.1.4.2 Products/Services offered
13.1.4.3 Recent developments
13.1.4.3.1 Product/Service launches, enhancements, and approvals
13.1.4.3.2 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 BIOM?RIEUX
13.1.5.1 Business overview
13.1.5.2 Products/Services offered
13.1.5.3 Recent developments
13.1.5.3.1 Product/Service launches, enhancements, and approvals
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 NEOGEN CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products/Services offered
13.1.6.3 Recent developments
13.1.6.3.1 Product/Service launches, enhancements, and approvals
13.1.6.3.2 Deals
13.1.6.3.3 Other developments
13.1.7 BIO-RAD LABORATORIES, INC.
13.1.7.1 Business overview
13.1.7.2 Products/Services offered
13.1.8 VIRBAC
13.1.8.1 Business overview
13.1.8.2 Products/Services offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.8.3.2 Expansions
13.1.9 FUJIFILM HOLDINGS CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products/Services offered
13.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
13.1.10.1 Business overview
13.1.10.2 Products/Services offered
13.1.10.3 Recent developments
13.1.10.3.1 Product/Service launches, enhancements, and approvals
13.1.10.3.2 Expansions
13.1.11 INDICAL BIOSCIENCE GMBH
13.1.11.1 Business overview
13.1.11.2 Products/Services offered
13.1.11.3 Recent developments
13.1.11.3.1 Product/Service launches, enhancements, and approvals
13.1.12 BIONOTE
13.1.12.1 Business overview
13.1.12.2 Products/Services offered
13.1.12.3 Recent developments
13.1.12.4 Product/Service launches, enhancements, and approvals
13.1.12.4.1 Deals
13.1.13 BIOGAL
13.1.13.1 Business overview
13.1.13.2 Products/Services offered
13.1.14 AGROLABO S.P.A.
13.1.14.1 Business overview
13.1.14.2 Products/Services offered
13.1.15 INNOVATIVE DIAGNOSTICS
13.1.15.1 Business overview
13.1.15.2 Products/Services offered
13.2 OTHER PLAYERS
13.2.1 RANDOX LABORATORIES LTD.
13.2.2 BIOCHEK
13.2.3 FASSISI, GMBH
13.2.4 ALVEDIA
13.2.5 SKYER, INC.
13.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
13.2.7 PRECISION BIOSENSOR, INC.
13.2.8 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
13.2.9 GOLD STANDARD DIAGNOSTICS
13.2.10 SKYLA CORPORATION
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 RELATED REPORTS
14.4 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS & REGIONS COVERED
1.2.3 YEARS CONSIDERED
1.3 MARKET STAKEHOLDERS
1.4 LIMITATIONS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ANALYSIS
2.6 RESEARCH ASSUMPTIONS
2.6.1 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
2.8 RESEARCH LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
4.3 VETERINARY DIAGNOSTICS MARKET: REGIONAL MIX
4.4 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Growth in companion animal population
5.1.1.2 Increasing demand for animal-derived food products
5.1.1.3 Growing concerns about infectious zoonotic diseases
5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
5.1.1.6 Growing focus on disease control & prevention measures
5.1.2 RESTRAINTS
5.1.2.1 Rising pet care costs
5.1.2.2 High cost of veterinary diagnostic tests
5.1.3 OPPORTUNITIES
5.1.3.1 Growth potential of emerging economies
5.1.3.2 Integration of AI & ML
5.1.4 CHALLENGES
5.1.4.1 Low animal healthcare awareness in emerging countries
5.1.4.2 Shortage of veterinary practitioners in emerging economies
5.2 INDUSTRY TRENDS
5.2.1 ADOPTION OF MULTIPLE TEST PANELS
5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Portable instruments for POC diagnostic services
5.3.1.2 Biosensor-based diagnostic systems
5.3.2 ADJACENT TECHNOLOGIES
5.3.2.1 Wearable biosensors & remote monitoring devices
5.3.2.2 Development of rapid & sensitive veterinary diagnostic kits
5.3.2.3 Breath & saliva-based diagnostic tools
5.3.2.4 Microfluidics & Lab-on-chip devices
5.3.3 COMPLEMENTARY TECHNOLOGIES
5.3.3.1 AI-driven diagnostic platforms
5.3.3.2 Next-generation Sequencing (NGS)
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY LANDSCAPE
5.5.1 REGULATORY ANALYSIS
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Rest of the world
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE DATA FOR HS CODE 9018
5.7.1.1 Import data for HS Code 9018
5.7.1.2 Export data for HS Code 9018
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2022–2024
5.8.1.1 Average selling price trend of key players, by product, 2022–2024
5.8.2 AVERAGE SELLING PRICE, BY REGION
5.8.2.1 Average selling price of clinical chemistry analyzers and blood gas & electrolyte analyzers, by region, 2024
5.8.2.2 Average selling price trend of clinical chemistry reagent clips & cartridges, by region, 2022–2024
5.8.2.3 Average selling price trend of clinical chemistry analyzers, by region, 2022–2024
5.8.2.4 Average selling price trend of blood glucose strips, by region, 2022–2024
5.8.2.5 Average selling price trend of glucose monitors, by region, 2022–2024
5.8.2.6 Average selling price trend of blood gas & electrolyte reagent clips/cartridges, by region
5.8.2.7 Average selling price trend of blood gas & electrolyte analyzers, by region, 2022–2024
5.9 REIMBURSEMENT ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2025–2026
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 BUYING CRITERIA
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI ON VETERINARY DIAGNOSTICS MARKET
5.13.1 INTRODUCTION
5.13.2 MARKET POTENTIAL IN VETERINARY DIAGNOSTICS ECOSYSTEM
5.13.3 AI-USE CASES
5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS
5.14 ECOSYSTEM/MARKET MAP
5.15 VALUE CHAIN ANALYSIS
5.16 SUPPLY CHAIN ANALYSIS
5.17 ADJACENT MARKETS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 TRUMP TARIFF IMPACT ON VETERINARY DIAGNOSTICS MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES
5.19.3 PRICE IMPACT ANALYSIS
5.19.4 IMPACT ON COUNTRY/REGION
5.19.5 IMPACT ON END-USE INDUSTRIES
6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 RECURRING NATURE TO BOOST DEMAND
6.3 INSTRUMENTS
6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET
7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 IMMUNODIAGNOSTICS
7.2.1 LATERAL FLOW ASSAYS
7.2.1.1 Lateral flow rapid tests
7.2.1.1.1 Ability to provide real-time insights to drive market
7.2.1.2 Lateral flow strip readers
7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
7.2.2 ELISA
7.2.2.1 Cost-effectiveness and ease of use to drive market
7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
7.2.3.1 Increasing incidence of allergies in companion animals to fuel market
7.2.4 IMMUNOASSAY ANALYZERS
7.2.4.1 High sensitivity & specificity for biomarker detection to drive market
7.2.5 RADIOIMMUNOASSAYS
7.2.5.1 Measurement of hormone levels and detection of specific proteins to fuel market
7.2.6 OTHER IMMUNODIAGNOSTIC PRODUCTS
7.3 CLINICAL BIOCHEMISTRY
7.3.1 CLINICAL CHEMISTRY ANALYSIS
7.3.1.1 Clinical chemistry reagent clips & cartridges
7.3.1.1.1 Rising number of screening tests to fuel market
7.3.1.2 Clinical chemistry analyzers
7.3.1.2.1 Increasing installation of clinical chemistry analyzers to propel market
7.3.2 GLUCOSE MONITORING
7.3.2.1 Blood glucose strips
7.3.2.1.1 Growing demand in home care settings to fuel market
7.3.2.2 Glucose monitors
7.3.2.2.1 Growing incidence of diabetes in pet animals to fuel adoption
7.3.2.3 Urine glucose strips
7.3.2.3.1 Increasing risk of DKA in animals to propel market
7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS
7.3.3.1 Blood gas & electrolyte reagent clips & cartridges
7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market
7.3.3.2 Blood gas & electrolyte analyzers
7.3.3.2.1 Determination of blood oxygen & carbon dioxide levels to drive market
7.4 MOLECULAR DIAGNOSTICS
7.4.1 PCR TESTS
7.4.1.1 Increased laboratory usage in proteomics & genomics to support growth
7.4.2 MICROARRAYS
7.4.2.1 Growing applications of biochips in identifying infectious diseases to drive market
7.4.3 NUCLEIC ACID SEQUENCING
7.4.3.1 Identification of pathogens to fuel market
7.4.4 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
7.5 HEMATOLOGY
7.5.1 HEMATOLOGY CARTRIDGES
7.5.1.1 Complete blood analysis capabilities to fuel market
7.5.2 HEMATOLOGY ANALYZERS
7.5.2.1 Adoption by veterinary hospitals & clinics to support market growth
7.6 URINALYSIS
7.6.1 URINALYSIS CLIPS & CARTRIDGES/PANELS
7.6.1.1 Detection of electrolytes to boost adoption
7.6.2 URINE ANALYZERS
7.6.2.1 Development of advanced analyzers for POC testing to support market growth
7.6.3 URINE TEST STRIPS
7.6.3.1 Increasing prevalence of CKD in cats & dogs to drive market
7.7 OTHER TECHNOLOGIES
8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 COMPANION ANIMALS
8.2.1 DOGS
8.2.1.1 High insurance coverage and availability of reimbursements to drive market
8.2.2 CATS
8.2.2.1 Increasing pet cat population to support market uptake
8.2.3 HORSES
8.2.3.1 Growing awareness regarding equine health to fuel market
8.2.4 OTHER COMPANION ANIMALS
8.3 LIVESTOCK
8.3.1 CATTLE
8.3.1.1 Growing consumption of dairy products to drive market
8.3.2 PIGS
8.3.2.1 Increasing incidence of infectious diseases to fuel market
8.3.3 POULTRY
8.3.3.1 Increasing demand for poultry meat contributes to market growth
8.3.4 OTHER LIVESTOCK ANIMALS
9 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 INFECTIOUS DISEASES
9.2.1 BACTERIAL INFECTIONS
9.2.1.1 Rapid spread of E. Coli to drive market
9.2.2 VIRAL INFECTIONS
9.2.2.1 High mutation rate to ensure continued demand for diagnostics
9.2.3 PARASITIC INFECTIONS
9.2.3.1 Presence of parasitic infections to fuel market
9.2.4 OTHER INFECTIONS
9.3 ENDOCRINOLOGY
9.3.1 GROWING RISK OF DIABETES TO BOOST DEMAND
9.4 CARDIOLOGY
9.4.1 INCREASING CASES OF CVD IN DOGS TO FUEL MARKET
9.5 ONCOLOGY
9.5.1 HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET
9.6 OTHER APPLICATIONS
10 VETERINARY DIAGNOSTICS MARKET, BY END USER
10.1 INTRODUCTION
10.2 VETERINARY REFERENCE LABORATORIES
10.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
10.3 VETERINARY HOSPITALS & CLINICS
10.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
10.4 POINT-OF-CARE/IN-HOUSE TESTING
10.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
10.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
10.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
11 VETERINARY DIAGNOSTICS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 High veterinary healthcare expenditure to drive market
11.2.3 CANADA
11.2.3.1 Growing pet adoption to drive market
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Rising awareness of zoonotic diseases to fuel market
11.3.3 UK
11.3.3.1 Increasing pet ownership to drive market
11.3.4 FRANCE
11.3.4.1 Willingness of pet owners to spend on pet health to drive market
11.3.5 ITALY
11.3.5.1 Growing consumption of meat & dairy products to drive market
11.3.6 SPAIN
11.3.6.1 Growing demand for poultry products to fuel market
11.3.7 NETHERLANDS
11.3.7.1 Developments in veterinary diagnostic products to support market growth
11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Increasing incidence of zoonotic diseases to propel market
11.4.3 JAPAN
11.4.3.1 Increasing pet expenditure to support market growth
11.4.4 INDIA
11.4.4.1 Increasing demand for dairy products to drive market
11.4.5 AUSTRALIA
11.4.5.1 Rise in pet ownership to support market growth
11.4.6 SOUTH KOREA
11.4.6.1 Rising need for specialized veterinary services to drive market
11.4.7 NEW ZEALAND
11.4.7.1 Focus on pet insurance to aid market
11.4.8 VIETNAM
11.4.8.1 Growing focus on disease surveillance to drive market
11.4.9 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Growth in livestock industry to boost demand
11.5.3 MEXICO
11.5.3.1 Increasing focus on poultry-associated products to support market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Kingdom of Saudi Arabia (KSA)
11.6.2.1.1 Technology advancements in veterinary diagnostics to boost demand
11.6.2.2 United Arab Emirates (UAE)
11.6.2.2.1 Favorable government support for vet diagnostics to drive market
11.6.2.3 Other GCC Countries
11.6.3 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.3 REVENUE ANALYSIS, 2020–2024
12.4 MARKET SHARE ANALYSIS
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Technology footprint
12.5.5.5 Animal type footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups
12.7 BRAND/PRODUCT COMPARATIVE ANALYSIS
12.8 R&D EXPENDITURE OF KEY PLAYERS
12.9 COMPANY VALUATION & FINANCIAL METRICS
12.9.1 FINANCIAL METRICS
12.9.2 COMPANY VALUATION
12.10 COMPETITIVE SCENARIO
12.10.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS
12.10.2 DEALS
12.10.3 EXPANSIONS
12.10.4 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 IDEXX LABORATORIES, INC.
13.1.1.1 Business overview
13.1.1.2 Products/Services offered
13.1.1.3 Recent developments
13.1.1.3.1 Product/Service launches, enhancements, and approvals
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 ZOETIS SERVICES LLC
13.1.2.1 Business overview
13.1.2.2 Products/Services offered
13.1.2.3 Recent developments
13.1.2.3.1 Product/Service launches, enhancements, and approvals
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 THERMO FISHER SCIENTIFIC INC.
13.1.3.1 Business overview
13.1.3.2 Products/Services offered
13.1.3.3 MnM view
13.1.3.3.1 Key strengths
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses & competitive threats
13.1.4 ANTECH DIAGNOSTICS, INC.
13.1.4.1 Business overview
13.1.4.2 Products/Services offered
13.1.4.3 Recent developments
13.1.4.3.1 Product/Service launches, enhancements, and approvals
13.1.4.3.2 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 BIOM?RIEUX
13.1.5.1 Business overview
13.1.5.2 Products/Services offered
13.1.5.3 Recent developments
13.1.5.3.1 Product/Service launches, enhancements, and approvals
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 NEOGEN CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products/Services offered
13.1.6.3 Recent developments
13.1.6.3.1 Product/Service launches, enhancements, and approvals
13.1.6.3.2 Deals
13.1.6.3.3 Other developments
13.1.7 BIO-RAD LABORATORIES, INC.
13.1.7.1 Business overview
13.1.7.2 Products/Services offered
13.1.8 VIRBAC
13.1.8.1 Business overview
13.1.8.2 Products/Services offered
13.1.8.3 Recent developments
13.1.8.3.1 Deals
13.1.8.3.2 Expansions
13.1.9 FUJIFILM HOLDINGS CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products/Services offered
13.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
13.1.10.1 Business overview
13.1.10.2 Products/Services offered
13.1.10.3 Recent developments
13.1.10.3.1 Product/Service launches, enhancements, and approvals
13.1.10.3.2 Expansions
13.1.11 INDICAL BIOSCIENCE GMBH
13.1.11.1 Business overview
13.1.11.2 Products/Services offered
13.1.11.3 Recent developments
13.1.11.3.1 Product/Service launches, enhancements, and approvals
13.1.12 BIONOTE
13.1.12.1 Business overview
13.1.12.2 Products/Services offered
13.1.12.3 Recent developments
13.1.12.4 Product/Service launches, enhancements, and approvals
13.1.12.4.1 Deals
13.1.13 BIOGAL
13.1.13.1 Business overview
13.1.13.2 Products/Services offered
13.1.14 AGROLABO S.P.A.
13.1.14.1 Business overview
13.1.14.2 Products/Services offered
13.1.15 INNOVATIVE DIAGNOSTICS
13.1.15.1 Business overview
13.1.15.2 Products/Services offered
13.2 OTHER PLAYERS
13.2.1 RANDOX LABORATORIES LTD.
13.2.2 BIOCHEK
13.2.3 FASSISI, GMBH
13.2.4 ALVEDIA
13.2.5 SKYER, INC.
13.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
13.2.7 PRECISION BIOSENSOR, INC.
13.2.8 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
13.2.9 GOLD STANDARD DIAGNOSTICS
13.2.10 SKYLA CORPORATION
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 RELATED REPORTS
14.4 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 VETERINARY DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
TABLE 3 VETERINARY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)
TABLE 8 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 VETERINARY DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSANDS)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSANDS)
TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
TABLE 16 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES, BY REGION, 2022–2024
TABLE 17 AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2022–2024
TABLE 18 AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2022–2024
TABLE 19 AVERAGE SELLING PRICE TREND OF GLUCOSE MONITORS, BY REGION, 2022–2024
TABLE 20 AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE REAGENT CLIPS/CARTRIDGES, BY REGION, 2022–2024
TABLE 21 AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2022–2024
TABLE 22 VETERINARY DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTIC PRODUCTS (%)
TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS
TABLE 25 VETERINARY DIAGNOSTIC PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 26 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 27 KEY PRODUCT-RELATED TARIFFS FOR VETERINARY DIAGNOSTICS
TABLE 28 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 29 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 31 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 32 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 33 VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34 KEY PLAYERS OFFERING VETERINARY DIAGNOSTIC CONSUMABLES
TABLE 35 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC INSTRUMENTS
TABLE 37 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 39 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 40 VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 41 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
TABLE 43 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 44 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
TABLE 46 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
TABLE 48 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 KEY PLAYERS PROVIDING ELISA TESTS
TABLE 50 ELISA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
TABLE 52 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
TABLE 54 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS
TABLE 56 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 58 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS
TABLE 60 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 61 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS
TABLE 63 CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 64 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES
TABLE 66 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS
TABLE 68 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 69 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70 KEY PLAYERS PROVIDING GLUCOSE MONITORING
TABLE 71 GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72 GLUCOSE MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS
TABLE 74 BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 75 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING GLUCOSE MONITORS
TABLE 77 GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 78 GLUCOSE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79 KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS
TABLE 80 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS
TABLE 82 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 83 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES
TABLE 85 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS
TABLE 87 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 88 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
TABLE 90 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92 KEY PLAYERS PROVIDING PCR TESTS
TABLE 93 PCR TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94 KEY PLAYERS PROVIDING MICROARRAYS
TABLE 95 MICROARRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
TABLE 97 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 99 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100 KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS
TABLE 101 VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103 KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES
TABLE 104 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105 KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS
TABLE 106 HEMATOLOGY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 107 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING URINALYSIS PRODUCTS
TABLE 109 VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111 KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES
TABLE 112 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 KEY PLAYERS PROVIDING URINE ANALYZERS
TABLE 114 URINE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 115 URINE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116 KEY PLAYERS PROVIDING URINE TEST STRIPS
TABLE 117 URINE TEST STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 118 URINE TEST STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119 KEY PLAYERS PROVIDING OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES
TABLE 120 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 122 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 123 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR DOGS
TABLE 126 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATS
TABLE 128 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR HORSES
TABLE 130 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER COMPANION ANIMALS
TABLE 132 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR LIVESTOCK
TABLE 134 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATTLE
TABLE 137 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PIGS
TABLE 139 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR POULTRY
TABLE 141 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER LIVESTOCK ANIMALS
TABLE 143 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 145 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR INFECTIOUS DISEASES
TABLE 146 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 148 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR BACTERIAL INFECTIONS
TABLE 149 VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR VIRAL INFECTIONS
TABLE 151 VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PARASITIC INFECTIONS
TABLE 153 VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER INFECTIONS
TABLE 155 VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ENDOCRINOLOGY APPLICATIONS
TABLE 157 VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CARDIOLOGY APPLICATIONS
TABLE 159 VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ONCOLOGY APPLICATIONS
TABLE 161 VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER APPLICATIONS
TABLE 163 VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 165 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2023) (USD)
TABLE 167 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 168 VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 170 VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 171 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 173 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 174 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 184 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 187 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 189 US: KEY MACRO INDICATORS
TABLE 190 US: VETERINARY DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 192 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 194 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196 US: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199 US: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200 US: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 202 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204 US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 205 US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206 US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 207 CANADA: KEY MACRO INDICATORS
TABLE 208 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 209 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 210 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214 CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217 CANADA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218 CANADA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 220 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222 CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 223 CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 225 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 226 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 227 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232 EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235 EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 236 EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 238 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 241 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 243 GERMANY: KEY MACRO INDICATORS
TABLE 244 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 245 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 246 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250 GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253 GERMANY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254 GERMANY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 256 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 259 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 260 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 261 UK: KEY MACRO INDICATORS
TABLE 262 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 263 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 264 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268 UK: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271 UK: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272 UK: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 274 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276 UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 277 UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 279 FRANCE: KEY MACRO INDICATORS
TABLE 280 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 281 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 282 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286 FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289 FRANCE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290 FRANCE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 292 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 295 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 297 ITALY: KEY MACRO INDICATORS
TABLE 298 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 299 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 300 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 303 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304 ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307 ITALY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308 ITALY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 310 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 312 ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 313 ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 315 SPAIN: KEY MACRO INDICATORS
TABLE 316 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 317 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 318 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 321 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322 SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 323 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 325 SPAIN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 326 SPAIN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 327 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 328 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 329 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 330 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 331 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 332 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 333 NETHERLANDS: KEY MACRO INDICATORS
TABLE 334 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 335 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 336 NETHERLANDS: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 337 NETHERLANDS: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 338 NETHERLANDS: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 339 NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 340 NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 341 NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 342 NETHERLANDS: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 343 NETHERLANDS: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 344 NETHERLANDS: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 345 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 346 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 347 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 348 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 349 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 350 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 351 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 352 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 353 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 354 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 355 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 356 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 357 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 358 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 359 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 360 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 361 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 362 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 363 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 364 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 365 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 366 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 367 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 368 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 369 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 370 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 371 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 372 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 373 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 374 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 375 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 376 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 377 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 378 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 379 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 380 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 381 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 382 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 383 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 384 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 385 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 386 CHINA: KEY MACRO INDICATORS
TABLE 387 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 388 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 389 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 VETERINARY DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
TABLE 3 VETERINARY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)
TABLE 8 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 VETERINARY DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSANDS)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSANDS)
TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
TABLE 16 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES, BY REGION, 2022–2024
TABLE 17 AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2022–2024
TABLE 18 AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2022–2024
TABLE 19 AVERAGE SELLING PRICE TREND OF GLUCOSE MONITORS, BY REGION, 2022–2024
TABLE 20 AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE REAGENT CLIPS/CARTRIDGES, BY REGION, 2022–2024
TABLE 21 AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2022–2024
TABLE 22 VETERINARY DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTIC PRODUCTS (%)
TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS
TABLE 25 VETERINARY DIAGNOSTIC PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 26 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 27 KEY PRODUCT-RELATED TARIFFS FOR VETERINARY DIAGNOSTICS
TABLE 28 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 29 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 31 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 32 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 33 VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34 KEY PLAYERS OFFERING VETERINARY DIAGNOSTIC CONSUMABLES
TABLE 35 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC INSTRUMENTS
TABLE 37 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 39 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 40 VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 41 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
TABLE 43 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 44 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
TABLE 46 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
TABLE 48 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 KEY PLAYERS PROVIDING ELISA TESTS
TABLE 50 ELISA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
TABLE 52 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
TABLE 54 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55 KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS
TABLE 56 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 58 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS
TABLE 60 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 61 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS
TABLE 63 CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 64 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES
TABLE 66 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS
TABLE 68 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 69 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70 KEY PLAYERS PROVIDING GLUCOSE MONITORING
TABLE 71 GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72 GLUCOSE MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS
TABLE 74 BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 75 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING GLUCOSE MONITORS
TABLE 77 GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 78 GLUCOSE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79 KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS
TABLE 80 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS
TABLE 82 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 83 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES
TABLE 85 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS
TABLE 87 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 88 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
TABLE 90 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92 KEY PLAYERS PROVIDING PCR TESTS
TABLE 93 PCR TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94 KEY PLAYERS PROVIDING MICROARRAYS
TABLE 95 MICROARRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
TABLE 97 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 99 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100 KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS
TABLE 101 VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103 KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES
TABLE 104 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105 KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS
TABLE 106 HEMATOLOGY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 107 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING URINALYSIS PRODUCTS
TABLE 109 VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111 KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES
TABLE 112 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113 KEY PLAYERS PROVIDING URINE ANALYZERS
TABLE 114 URINE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 115 URINE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116 KEY PLAYERS PROVIDING URINE TEST STRIPS
TABLE 117 URINE TEST STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 118 URINE TEST STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119 KEY PLAYERS PROVIDING OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES
TABLE 120 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 122 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 123 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR DOGS
TABLE 126 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATS
TABLE 128 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR HORSES
TABLE 130 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER COMPANION ANIMALS
TABLE 132 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR LIVESTOCK
TABLE 134 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATTLE
TABLE 137 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PIGS
TABLE 139 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR POULTRY
TABLE 141 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER LIVESTOCK ANIMALS
TABLE 143 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 145 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR INFECTIOUS DISEASES
TABLE 146 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 148 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR BACTERIAL INFECTIONS
TABLE 149 VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR VIRAL INFECTIONS
TABLE 151 VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PARASITIC INFECTIONS
TABLE 153 VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER INFECTIONS
TABLE 155 VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ENDOCRINOLOGY APPLICATIONS
TABLE 157 VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CARDIOLOGY APPLICATIONS
TABLE 159 VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ONCOLOGY APPLICATIONS
TABLE 161 VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER APPLICATIONS
TABLE 163 VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 165 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2023) (USD)
TABLE 167 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 168 VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 170 VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 171 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 173 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 174 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 184 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 187 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 189 US: KEY MACRO INDICATORS
TABLE 190 US: VETERINARY DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 192 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 194 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196 US: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199 US: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200 US: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 202 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204 US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 205 US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206 US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 207 CANADA: KEY MACRO INDICATORS
TABLE 208 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 209 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 210 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214 CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217 CANADA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218 CANADA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 220 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222 CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 223 CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 225 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 226 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 227 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232 EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235 EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 236 EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 238 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 241 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 243 GERMANY: KEY MACRO INDICATORS
TABLE 244 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 245 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 246 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250 GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253 GERMANY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254 GERMANY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 256 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 259 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 260 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 261 UK: KEY MACRO INDICATORS
TABLE 262 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 263 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 264 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268 UK: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271 UK: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272 UK: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 274 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276 UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 277 UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 279 FRANCE: KEY MACRO INDICATORS
TABLE 280 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 281 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 282 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286 FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289 FRANCE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290 FRANCE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 292 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 295 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 297 ITALY: KEY MACRO INDICATORS
TABLE 298 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 299 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 300 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 303 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304 ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307 ITALY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308 ITALY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 310 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 312 ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 313 ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 315 SPAIN: KEY MACRO INDICATORS
TABLE 316 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 317 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 318 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 321 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322 SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 323 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 325 SPAIN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 326 SPAIN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 327 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 328 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 329 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 330 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 331 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 332 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 333 NETHERLANDS: KEY MACRO INDICATORS
TABLE 334 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 335 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 336 NETHERLANDS: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 337 NETHERLANDS: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 338 NETHERLANDS: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 339 NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 340 NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 341 NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 342 NETHERLANDS: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 343 NETHERLANDS: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 344 NETHERLANDS: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 345 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 346 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 347 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 348 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 349 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 350 NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 351 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 352 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 353 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 354 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 355 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 356 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 357 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 358 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 359 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 360 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 361 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 362 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 363 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 364 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 365 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 366 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 367 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 368 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 369 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 370 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 371 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 372 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 373 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 374 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 375 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 376 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 377 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 378 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 379 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 380 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 381 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 382 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 383 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 384 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 385 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 386 CHINA: KEY MACRO INDICATORS
TABLE 387 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 388 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 389 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 VETERINARY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SPREAD
FIGURE 2 VETERINARY DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY DIAGNOSTICS MARKET (2024)
FIGURE 10 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2025–2030)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
FIGURE 14 BOTTOM-UP APPROACH
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 18 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 19 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 20 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 21 GEOGRAPHIC SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET
FIGURE 22 GROWING PREVALENCE OF ZOONOTIC DISEASES TO PROPEL MARKET
FIGURE 23 CONSUMABLES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 24 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 27 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 28 EUROPE: PET POPULATION, 2021–2023
FIGURE 29 US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)
FIGURE 30 PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 VETERINARY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2014–MAY 2025)
FIGURE 33 AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY KEY PLAYER, 2024
FIGURE 34 AVERAGE SELLING PRICE FOR CLINICAL CHEMISTRY ANALYZERS AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2024
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 37 AI-USE CASES
FIGURE 38 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
FIGURE 39 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 40 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 41 VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS
FIGURE 42 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 43 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 44 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 45 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 46 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 47 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2022–2024)
FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2024)
FIGURE 50 RANKING OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2024
FIGURE 51 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2024
FIGURE 52 VETERINARY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 53 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 54 VETERINARY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 55 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2022–2024
FIGURE 56 EV/EBITDA OF KEY VENDORS
FIGURE 57 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 58 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 59 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
FIGURE 60 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 61 BIOM?RIEUX: COMPANY SNAPSHOT (2024)
FIGURE 62 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 63 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 64 VIRBAC: COMPANY SNAPSHOT (2024)
FIGURE 65 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 66 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2024)
FIGURE 1 VETERINARY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SPREAD
FIGURE 2 VETERINARY DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY DIAGNOSTICS MARKET (2024)
FIGURE 10 VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2025–2030)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
FIGURE 14 BOTTOM-UP APPROACH
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 18 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 19 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 20 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 21 GEOGRAPHIC SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET
FIGURE 22 GROWING PREVALENCE OF ZOONOTIC DISEASES TO PROPEL MARKET
FIGURE 23 CONSUMABLES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 24 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 27 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 28 EUROPE: PET POPULATION, 2021–2023
FIGURE 29 US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)
FIGURE 30 PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 VETERINARY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2014–MAY 2025)
FIGURE 33 AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY KEY PLAYER, 2024
FIGURE 34 AVERAGE SELLING PRICE FOR CLINICAL CHEMISTRY ANALYZERS AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2024
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 37 AI-USE CASES
FIGURE 38 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
FIGURE 39 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 40 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 41 VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS
FIGURE 42 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 43 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 44 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 45 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 46 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 47 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2022–2024)
FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2024)
FIGURE 50 RANKING OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2024
FIGURE 51 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2024
FIGURE 52 VETERINARY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 53 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 54 VETERINARY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 55 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2022–2024
FIGURE 56 EV/EBITDA OF KEY VENDORS
FIGURE 57 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 58 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 59 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
FIGURE 60 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 61 BIOM?RIEUX: COMPANY SNAPSHOT (2024)
FIGURE 62 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 63 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 64 VIRBAC: COMPANY SNAPSHOT (2024)
FIGURE 65 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 66 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2024)
